Mounjaro vs Saxenda

Mounjaro (tirzepatide) is a once-weekly injection made by Eli Lilly for treating type 2 diabetes, while Saxenda (liraglutide) is a daily injection by Novo Nordisk approved for weight management in people with obesity. Both are given under the skin, but Mounjaro is used for blood sugar control in diabetes, whereas Saxenda is for long-term weight loss. The active ingredients and dosing schedules differ, with Mounjaro taken weekly and Saxenda daily.

AI summary of the sources below.